Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.

Damond, F; Brun-Vezinet, F; Matheron, S; Peytavin, G; Campa, P; Pueyo, S; Mammano, F; Lastere, S; Farfara, I; Simon, F; Chene, G; Descamps, D

Damond, F; Brun-Vezinet, F; Matheron, S; Peytavin, G; Campa, P; Pueyo, S; Mammano, F; Lastere, S; Farfara, I; Simon, F; Chene, G; Descamps, D.

Affiliation

Damond F; Hôpital Bichat-Claude Bernard, Paris, France.

J Clin Microbiol ; 43(1): 484-7, 2005 Jan.

Article in En | MEDLINE | ID: mdl-15635022

Subject(s)

HIV Protease/genetics; Mutation; Polymorphism, Genetic; Adult; Drug Resistance, Viral/genetics; Female; HIV Infections/drug therapy; HIV Infections/virology; HIV Protease Inhibitors/pharmacology; HIV Protease Inhibitors/therapeutic use; HIV-2/drug effects; HIV-2/enzymology; HIV-2/genetics; Humans; Male

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymorphism, Genetic / HIV Protease / Mutation Limits: Adult / Female / Humans / Male Language: En Journal: J Clin Microbiol Year: 2005 Document type: Article Affiliation country: France Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google